• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Meta-Analysis Assessing the Cardiovascular Efficacy of Sodium-Glucose Co-Transporter-2 Inhibitors According to Baseline Treatment of Interest.

作者信息

Patoulias Dimitrios, Papadopoulos Christodoulos, Katsimardou Alexandra, Doumas Michael

机构信息

Second Propedeutic Department of Internal Medicine, Aristotle University of Thessaloniki, General Hospital "Hippokration", Greece.

Third Department of Cardiology, Aristotle University of Thessaloniki, General Hospital "Hippokration", Greece.

出版信息

Am J Cardiol. 2021 Jan 15;139:134-136. doi: 10.1016/j.amjcard.2020.10.029. Epub 2020 Oct 16.

DOI:10.1016/j.amjcard.2020.10.029
PMID:33075281
Abstract
摘要

相似文献

1
Meta-Analysis Assessing the Cardiovascular Efficacy of Sodium-Glucose Co-Transporter-2 Inhibitors According to Baseline Treatment of Interest.根据感兴趣的基线治疗评估钠-葡萄糖协同转运蛋白2抑制剂心血管疗效的Meta分析
Am J Cardiol. 2021 Jan 15;139:134-136. doi: 10.1016/j.amjcard.2020.10.029. Epub 2020 Oct 16.
2
Counterpoint to the hypothesis that SGLT2 inhibitors protect the heart by antagonizing leptin.与钠-葡萄糖协同转运蛋白2（SGLT2）抑制剂通过拮抗瘦素保护心脏这一假说相反的观点
Diabetes Obes Metab. 2018 Jun;20(6):1367-1368. doi: 10.1111/dom.13234. Epub 2018 Feb 21.
3
Do sodium-glucose co-transporter-2 inhibitors prevent heart failure with a preserved ejection fraction by counterbalancing the effects of leptin? A novel hypothesis.钠-葡萄糖协同转运蛋白 2 抑制剂是否通过平衡瘦素的作用来预防射血分数保留的心力衰竭？一个新的假说。
Diabetes Obes Metab. 2018 Jun;20(6):1361-1366. doi: 10.1111/dom.13229. Epub 2018 Feb 20.
4
Primary Prevention of Heart Failure in Patients With Type 2 Diabetes Mellitus.2型糖尿病患者心力衰竭的一级预防
Circulation. 2019 Jan 8;139(2):152-154. doi: 10.1161/CIRCULATIONAHA.118.037599.
5
Promise, Innovation, Potency, and Efficacy: The PIPE Dream of Sodium-Glucose Co-Transporter 2 Inhibitors.前景、创新、潜力与疗效：钠-葡萄糖协同转运蛋白2抑制剂的白日梦
Am J Cardiol. 2019 Dec 15;124 Suppl 1:S1-S2. doi: 10.1016/j.amjcard.2019.10.023.
6
Treating Heart Failure With Antihyperglycemic Medications: Is Now the Right Time?使用抗高血糖药物治疗心力衰竭：现在是合适的时机吗？
Circulation. 2019 May 21;139(21):2383-2385. doi: 10.1161/CIRCULATIONAHA.119.038854.
7
Does Metformin Interfere With the Cardiovascular Benefits of SGLT2 Inhibitors? Questions About Its Role as the Cornerstone of Diabetes Treatment.二甲双胍是否会干扰钠-葡萄糖协同转运蛋白2（SGLT2）抑制剂的心血管益处？关于其作为糖尿病治疗基石作用的疑问。
Am J Med. 2020 Jul;133(7):781-782. doi: 10.1016/j.amjmed.2020.01.016. Epub 2020 Feb 12.
8
[Not Available].[无可用内容]
Rev Med Interne. 2020 Feb;41(2):143-144. doi: 10.1016/j.revmed.2019.12.011. Epub 2020 Jan 9.
9
Research digest: new horizons in heart failure therapy.研究摘要：心力衰竭治疗的新视野
Lancet Diabetes Endocrinol. 2019 Nov;7(11):832. doi: 10.1016/S2213-8587(19)30315-8.
10
Updated Meta-analysis Assessing the Effect of Sodium-Glucose Co-transporter-2 Inhibitors on Surrogate End points in Patients With Heart Failure With Reduced Ejection Fraction.评估钠-葡萄糖协同转运蛋白2抑制剂对射血分数降低的心力衰竭患者替代终点影响的更新荟萃分析。
Am J Cardiol. 2020 Dec 15;137:130-132. doi: 10.1016/j.amjcard.2020.10.001. Epub 2020 Oct 10.